Chemical Analysis, Life Sciences, and Diagnostics | Agilent
Agilent delivers complete scientific solutions, helping customers achieve superior outcomes in their labs, clinics, business and the world they seek to improve.
About Agilent
Agilent supports scientists in 110 countries in cutting-edge life science research; patient diagnostics; and testing required to ensure the safety of water, food and pharmaceuticals Our advanced instruments, software, consumables, and services enable our customers to produce the most accurate and reliable results as well as optimal scientific ...
Agilent - Who We Are
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek.
Agilent Technologies, Inc. - Investor Overview
Agilent Technologies Inc. is a global leader in the life sciences, diagnostics, and applied markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions.
Agilent Investing $725 Million to Expand State-of-the-Art …
Agilent Technologies Inc. (NYSE: A) today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active pharmaceutical ingredients (API).
Agilent Technologies, Inc. - Agilent Reports Fourth-Quarter Fiscal …
2024年11月25日 · SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.70 billion for the fourth quarter ended October 31, 2024, an increase of 0.8% reported and a decline of 0.3% core (1) compared to the fourth quarter of 2023.
Agilent Technologies, Inc. - Agilent to Announce Second-Quarter …
2024年5月2日 · Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2024 after the stock market closes on May 29. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PT.
Next-Generation Sequencing (NGS) solutions - Agilent
Empower your genomic analysis with Agilent’s comprehensive portfolio of next-generation sequencing (NGS) solutions. Featuring Agilent SureSelect and Avida library preparation and target enrichment reagents, our connected solutions offer reliable data and insights.
Agilent to Host Analyst and Investor Day on Dec. 17, 2024
2024年9月30日 · Agilent Technologies Inc. (NYSE: A) will host an Analyst and Investor Day in New York City on Tuesday, Dec. 17, at 10 a.m. ET. CEO Padraig McDonnell, CFO Bob McMahon, and other senior business leaders will present information regarding Agilent’s strategy, businesses, and long-term financial outlook.
Agilent Technologies, Inc. - Agilent Completes Acquisition of …
2024年9月20日 · SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO) that specializes in biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics.